Tyrosine Kinases as Druggable Targets in Cancer
Protein tyrosine kinase (PTK) deregulation contributes to growth of cancer and many other diseases. The development of small-molecule tyrosine kinase inhibitors (TKIs) that target the deregulated PTKs, such as epidermal growth factor receptor (EGFR) in non-small-cell lung cancer (NSCLC) and Bcr-ABL...
Saved in:
Other Authors: | Ren, Huan (Editor) |
---|---|
Format: | Electronic Book Chapter |
Language: | English |
Published: |
IntechOpen
2019
|
Subjects: | |
Online Access: | DOAB: download the publication DOAB: description of the publication |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
Pancreatic Cancer Molecular Mechanism and Targets
Published: (2012) -
Molecular Targets of CNS Tumors
Published: (2011) -
Oncogenomics and Cancer Proteomics Novel Approaches in Biomarkers Discovery and Therapeutic Targets in Cancer
Published: (2013) -
Novel Therapeutic Concepts in Targeting Glioma
Published: (2012) -
Carcinogenesis, Diagnosis, and Molecular Targeted Treatment for Nasopharyngeal Carcinoma
Published: (2012)